ArticleInvestigational new drugs2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
David C Smith et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it